The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters
Open accessAbstract
The pathogenesis of multiple sclerosis (MS), an autoimmune disease affecting the brain and spinal cord, remains poorly understood. Patients with MS typically present with recurrent episodes of neurological dysfunctions such as blindness, paresis, and sensory disturbances. Studies on experimental autoimmune encephalomyelitis (EAE) animal models have led to a number of testable hypotheses including a hypothetical role of altered gut microbiota in the development of MS. To investigate whether gut microbiota in patients with MS is altered, we compared the gut microbiota of 20 Japanese patients with relapsing-remitting (RR) MS (MS20) with that of 40 healthy Japanese subjects (HC40) and an additional 18 healthy subjects (HC18). All the HC18 subjects repeatedly provided fecal samples over the course of months (158 samples in total). Analysis of the bacterial 16S ribosomal RNA (rRNA) gene by using a high-throughput culture-independent pyrosequencing method provided evidence of a moderate dysbiosis in the structure of gut microbiota in patients with MS. Furthermore, we found 21 species that showed significant differences in relative abundance between the MS20 and HC40 samples. On comparing MS samples to the 158 longitudinal HC18 samples, the differences were found to be reproducibly significant for most of the species. These taxa comprised primarily of clostridial species belonging to Clostridia clusters XIVa and IV and Bacteroidetes. The phylogenetic tree analysis revealed that none of the clostridial species that were significantly reduced in the gut microbiota of patients with MS overlapped with other spore-forming clostridial species capable of inducing colonic regulatory T cells (Treg), which prevent autoimmunity and allergies; this suggests that many of the clostridial species associated with MS might be distinct from those broadly associated with autoimmune conditions. Correcting the dysbiosis and altered gut microbiota might deserve consideration as a potential strategy for the prevention and treatment of MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig 5 Phylogenetic tree of 14 clostridial species exhibiting significant differences among groups and several known species. The neighbor-joining method was used to construct the phylogenetic tree. Numbers at each node indicate the bootstrap support (1,000 replicates). Those written in red letters are 14 clostridial species having a significant difference in relative abundance between HC40 and MS20 samples. Treg-inducing strains are indicated by “St” and are written in blue letters [13].](/paper-figures/cabefd3c1856464fb7f6cfb12c4b3815/dysbiosis-in-the-gut-microbiota-of-patients-with-multiple-sclerosis-with-a-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bacteria belonging to the Clostridia family contribute to the suppression of pathological autoimmunity (134, 139–143).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [134]
In the citing paper
“Interestingly, even MS patients with active disease have an altered microbiota compared to patients in the remission phase, which in turn have a microbiota more similar to healthy controls (25, 134–138).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
Cited by
Sorted by citations
Items 101–200 of 810
The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
König, R. S., Albrich, W. C., Kahlert, C. R., Bahr, L. S., Löber, U., Vernazza, P., Scheibenbogen, C., & Forslund, S. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.628741 · Cited by 133
Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity
Montgomery, T. L., Künstner, A., Kennedy, J. J., Fang, Q., Asarian, L., Culp‐Hill, R., D’Alessandro, A., Teuscher, C., Busch, H. S., & Krementsov, D. N. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002817117 · Cited by 121
Implications of Diet and The Gut Microbiome in Neuroinflammatory and Neurodegenerative Diseases
Hirschberg, S., Gisevius, B., Duscha, A., & Haghikia, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123109 · Cited by 120
Challenges and Limitations of Anti-quorum Sensing Therapies
Krzyżek, P. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02473 · Cited by 126
Gut Vibes in Parkinson's Disease: The Microbiota‐Gut‐Brain Axis
Bullich‐Vilarrubias, C., Keshavarzian, A., Garssen, J., Kraneveld, A. D., & Perez‐Pardo, P. (2019) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12840 · Cited by 120
The ecology of human microbiota: dynamics and diversity in health and disease
Karkman, A., Lehtimäki, J., & Ruokolainen, L. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13326 · Cited by 117
Tremlett, H. L., Fadrosh, D. W., Faruqi, A. A., Hart, J., Roalstad, S., Graves, J., Spencer, C. M., Lynch, S. V., Zamvil, S. S., & Waubant, E. L. (2016) · BMC Neurology · doi:10.1186/s12883-016-0703-3 · Cited by 117
Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes
Reynders, T., Devolder, L., Valles‐Colomer, M., Remoortel, A. V., Joossens, M., Keyser, J. D., Nagels, G., D'hooghe, M. B., & Raes, J. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51004 · Cited by 113
Regulation of common neurological disorders by gut microbial metabolites
Park, J., & Kim, C. H. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00703-x · Cited by 126
Psychological Stress, Intestinal Barrier Dysfunctions, and Autoimmune Disorders: An Overview
Ilchmann-Diounou, H., & Ménard, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01823 · Cited by 125
Targeting the gut to treat multiple sclerosis
Ghezzi, L., Cantoni, C., Pinget, G. V., Zhou, Y., & Piccio, L. M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143774 · Cited by 116
Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation
Zundler, S., Günther, C., Kremer, A. E., Zaiss, M. M., Rothhammer, V., & Neurath, M. F. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00663-1 · Cited by 112
Pröbstel, A.-K., & Baranzini, S. E. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0587-y · Cited by 110
Invited Review: From nose to gut – the role of the microbiome in neurological disease
Bell, J. S., Spencer, J. I., Yates, R. L., Yee, S. A., Jacobs, B. M., & DeLuca, G. C. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12520 · Cited by 111
Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use
Naito, Y., Kashiwagi, K., Takagi, T., Andoh, A., & Inoüe, R. (2018) · Digestion · doi:10.1159/000481813 · Cited by 109
Abe, K., Takahashi, A., Fujita, M., Imaizumi, H., Hayashi, M., Okai, K., & Ohira, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198757 · Cited by 110
Planas, R., Santos, R. G., Ojer, P. T., Cruciani, C., Lutterotti, A., Faigle, W., Schaeren‐Wiemers, N., Espejo, C., Eixarch, H., Pinilla, C., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat4301 · Cited by 115
Praveenraj, S. S., Sonali, S., Anand, N., Hediyal, T. A., Vichitra, C., Kalyan, M., Kanna, P. V., Chandana, K. A., Paneyala, S., Mahalakshmi, A. M., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02990-5 · Cited by 116
Disease-modifying therapies alter gut microbial composition in MS
Sand, I. K., Zhu, Y., Ntranos, A., Clemente, J. C., Cekanaviciute, E., Brandstadter, R., Crabtree‐Hartman, E., Singh, S., Bencosme, Y., Debelius, J. W., et al. (2018) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000517 · Cited by 106
The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue
Kirby, T. O., & Ochoa‐Repáraz, J. (2018) · Medical Sciences · doi:10.3390/medsci6030069 · Cited by 114
Gut microbiome of treatment-naïve MS patients of different ethnicities early in disease course
Ventura, R. E., Iizumi, T., Battaglia, T., Liu, M., Perez-Perez, G. I., Herbert, J., & Blaser, M. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-52894-z · Cited by 106
Haran, J. P., Bucci, V., Dutta, P., Ward, D., & McCormick, B. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000640 · Cited by 97
Gut bacterial composition in a mouse model of Parkinson’s disease
Perez-Pardo, P., Dodiya, H. B., Engen, P. A., Naqib, A., Forsyth, C. B., Green, S. J., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0202 · Cited by 102
Dopkins, N., Nagarkatti, P. S., & Nagarkatti, M. (2018) · Immunology · doi:10.1111/imm.12903 · Cited by 110
Brain Autoimmunity and Intestinal Microbiota: 100 Trillion Game Changers
Wekerle, H. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.03.008 · Cited by 104
Morris, G., Berk, M., Klein, H. C., Walder, K. R., Gałecki, P., & Maes, M. H. J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9975-2 · Cited by 100
Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders
Shahbazi, R., Yasavoli‐Sharahi, H., Alsadi, N., Ismail, N., & Matar, C. (2020) · Molecules · doi:10.3390/molecules25214891 · Cited by 102
Levi, I., Gurevich, M., Perlman, G., Magalashvili, D., Menascu, S., Bar, N., Godneva, A., Zahavi, L., Chermon, D., Kosower, N., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100246 · Cited by 99
Long-term metal exposure changes gut microbiota of residents surrounding a mining and smelting area
Shao, M., & Zhu, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-61143-7 · Cited by 98
Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis
Calvo‐Barreiro, L., Eixarch, H., Montalbán, X., & Espejo, C. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.11.019 · Cited by 95
Gandy, K. A. O., Zhang, J., Nagarkatti, P. S., & Nagarkatti, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-43356-7 · Cited by 97
Protection of Fecal Microbiota Transplantation in a Mouse Model of Multiple Sclerosis
Li, K., Wei, S., Hu, L., Yin, X., Mai, Y., Jiang, C., Peng, X., Cao, X., Huang, Z., Zhou, H., et al. (2020) · Mediators of Inflammation · doi:10.1155/2020/2058272 · Cited by 92
Gut microbiome interventions in human health and diseases
Nie, P., Li, Z., Wang, Y., Zhang, Y., Zhao, M., Luo, J., Du, S., Deng, Z., Chen, J., Wang, Y., et al. (2019) · Medicinal Research Reviews · doi:10.1002/med.21584 · Cited by 94
Fungi as Part of the Microbiota and Interactions with Intestinal Bacteria
Kapitan, M., Niemiec, M. J., Steimle, A., Frick, J.-S., & Jacobsen, I. D. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_117 · Cited by 101
Xu, Y., Xiang, S., Ye, K., Zheng, Y., Feng, X., Zhu, X., Chen, J., & Chen, Y. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02780 · Cited by 97
The Gut–CNS Axis in Multiple Sclerosis
Kadowaki, A., & Quintana, F. J. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.06.002 · Cited by 95
Colpitts, S. L., Kasper, E. J., Keever, A., Liljenberg, C., Kirby, T. O., Mágori, K., Kasper, L. H., & Ochoa‐Repáraz, J. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1353843 · Cited by 93
Muñoz-Jurado, A., Escribano, B. M., Caballero‐Villarraso, J., Galván, A., Agüera, E., Santamarı́a, A., & Túnez, I. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01011-0 · Cited by 100
Altered Gut Microbiota in Myasthenia Gravis
Qiu, D., Xia, Z., Jiao, X., Deng, J., Zhang, L., & Li, J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02627 · Cited by 98
Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
Boziki, M. K., Kesidou, E., Theotokis, P., Mentis, A. A., Karafoulidou, E., Melnikov, M., Sviridova, A. A., Rogovskii, V., Boyко, A., & Grigoriadis, N. (2020) · Brain Sciences · doi:10.3390/brainsci10040234 · Cited by 93
Berer, K., Martínez, I., Walker, A., Kunkel, B., Schmitt‐Kopplin, P., Walter, J., & Krishnamoorthy, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-28839-3 · Cited by 90
Secombe, K. R., Coller, J. K., Gibson, R. J., Wardill, H. R., & Bowen, J. M. (2018) · International Journal of Cancer · doi:10.1002/ijc.31836 · Cited by 92
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
Takeuchi, Y., Hirota, K., & Sakaguchi, S. (2020) · Immunological Reviews · doi:10.1111/imr.12841 · Cited by 90
High animal protein diet and gut microbiota in human health
Cai, J., Chen, Z., Wu, W., Lin, Q., & Liang, Y. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1898336 · Cited by 102
Bahr, L. S., Bock, M., Liebscher, D., Bellmann–Strobl, J., Franz, L., Prüß, A., Schumann, D., Piper, S. K., Keßler, C. S., Steckhan, N., et al. (2020) · Trials · doi:10.1186/s13063-019-3928-9 · Cited by 92
Alterations of the Fecal Microbiota in Chinese Patients With Multiple Sclerosis
Ling, Z., Cheng, Y., Yan, X., Shao, L., Liu, X., Zhou, D., Zhang, L., Yu, K., & Zhao, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.590783 · Cited by 92
Gut Microbiome in Inflammatory Bowel Disease and Other Chronic Immune-Mediated Inflammatory Diseases
Bernstein, C. N., & Forbes, J. D. (2017) · Inflammatory Intestinal Diseases · doi:10.1159/000481401 · Cited by 88
Retinoic Acid, Leaky Gut, and Autoimmune Diseases
Abdelhamid, L., & Luo, X. (2018) · Nutrients · doi:10.3390/nu10081016 · Cited by 90
Cencicchio, M. A., Conte, M. L., Sorini, C., & Falcone, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01937 · Cited by 91
Engen, P. A., Zaferiou, A. M., Rasmussen, H. E., Naqib, A. D., Green, S. J., Fogg, L., Forsyth, C. B., Raeisi, S., Hamaker, B. R., & Keshavarzian, A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00978 · Cited by 90
The gut microbiome and microbial translocation in multiple sclerosis
Mirza, A., & Mao‐Draayer, Y. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.03.001 · Cited by 92
The role of the intestinal microbiome in ocular inflammatory disease
Lin, P. (2018) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000465 · Cited by 87
Lombardi, V. C., Meirleir, K. L. D., Subramanian, K., Nourani, S. M., Dagda, R. K., Delaney, S. L., & Palotás, A. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.04.004 · Cited by 87
Janowitz, C., Nakamura, Y., Metea, C., Gligor, A., Yu, W., Karstens, L., Rosenbaum, J. T., Asquith, M. J., & Lin, P. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24813 · Cited by 84
Sun, Y., Zhang, Z., Cheng, L., Zhang, X., Liu, Y., Zhang, R., Weng, P., & Wu, Z. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110675 · Cited by 85
Knox, N., Forbes, J. D., Peterson, C.-L., Domselaar, G. V., & Bernstein, C. N. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000305 · Cited by 87
Molecular Insight into Gut Microbiota and Rheumatoid Arthritis
Wu, X., He, B., Liu, J., Feng, H., Ma, Y., Li, D., Guo, B., Liang, C., Dang, L., Wang, L., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030431 · Cited by 85
Tilocca, B., Pieroni, L., Soggiù, A., Britti, D., Bonizzi, L., Roncada, P., & Greco, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114045 · Cited by 86
Gut Microbiota as Regulators of Th17/Treg Balance in Patients With Myasthenia Gravis
Chen, P., & Tang, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.803101 · Cited by 86
Bianchimano, P., Britton, G. J., Wallach, D. S., Smith, E. M., Cox, L. M., Liu, S., Iwanowski, K., Weiner, H. L., Faith, J. J., Clemente, J. C., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01364-2 · Cited by 83
Shimizu, J., Kubota, T., Takada, E., Takai, K., Fujiwara, N., Arimitsu, N. N., Ueda, Y., Wakisaka, S., Tomoko, S., & Suzuki, N. (2019) · Clinical Rheumatology · doi:10.1007/s10067-018-04419-8 · Cited by 78
Johanson, D. M., Goertz, J. E., Marin, I. A., Costello, J., Overall, C. C., & Gaultier, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-72197-y · Cited by 77
Han, B., Shi, L., Bao, M.-Y., Yu, F.-L., Zhang, Y., Lu, X., Wang, Y., Lin, J., Lin, J.-C., Jia, W., et al. (2024) · Microbiome · doi:10.1186/s40168-024-01819-8 · Cited by 84
Shang, Q., Wang, Y., Pan, L., Niu, Q., Li, C., Jiang, H., Cai, C., Hao, J., Li, G., & Yu, G. (2018) · Marine Drugs · doi:10.3390/md16050167 · Cited by 75
Trend, S., Leffler, J., Jones, A. P., Cha, L., Gorman, S., Brown, D. A., Breit, S. N., Kermode, A. G., French, M. A., Ward, N. C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84881-8 · Cited by 75
Gut microbiome differences between amyotrophic lateral sclerosis patients and spouse controls
Hertzberg, V., Singh, H., Fournier, C. N., Moustafa, A., Polak, M. A., Kuelbs, C., Torralba, M., Tansey, M. G., Nelson, K. E., & Glass, J. D. (2021) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2021.1904994 · Cited by 81
Alterations of the gut mycobiome in patients with MS
Shah, S., Locca, A., Dorsett, Y., Cantoni, C., Ghezzi, L., Lin, Q., Bokoliya, S. C., Panier, H. A., Suther, C., Gormley, M., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103557 · Cited by 75
The tryptophan metabolic pathway of the microbiome and host cells in health and disease
Miyamoto, K., Sujino, T., & Kanai∥, T. (2024) · International Immunology · doi:10.1093/intimm/dxae035 · Cited by 85
Morris, G., Reiche, E. M. V., Murru, A., Carvalho, A. F., Maes, M. H. J., Berk, M., & Puri, B. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0843-5 · Cited by 75
Innate Sensing of the Gut Microbiota: Modulation of Inflammatory and Autoimmune Diseases
Ignácio, A., Morales, C., Câmara, N. O. S., & Almeida, R. R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00054 · Cited by 75
Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome
Camara-Lemarroy, C. R., Metz, L. M., & Yong, V. W. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i37.4217 · Cited by 77
van den Hoogen, W., Laman, J. D., & Hart, B. A. ‘. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01081 · Cited by 76
The Gut Microbiome in Neuromyelitis Optica
Zamvil, S. S., Spencer, C. M., Baranzini, S. E., & Cree, B. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0594-z · Cited by 73
Recent Advances on Microbiota Involvement in the Pathogenesis of Autoimmunity
Gianchecchi, E., & Fierabracci, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020283 · Cited by 77
Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis
Kadowaki, A., Saga, R., Lin, Y., Sato, W., & Yamamura, T. (2019) · Brain · doi:10.1093/brain/awz012 · Cited by 79
Jensen, S. N., Cady, N. M., Shahi, S. K., Peterson, S. R., Gupta, A. A., Gibson-Corley, K. N., & Mangalam, A. K. (2021) · Science Advances · doi:10.1126/sciadv.abd4595 · Cited by 76
Human gut microbes are susceptible to antimicrobial food additives in vitro
Hrncirova, L., Hudcovic, T., Sukova, E., Machova, V., Trckova, E., Krejsek, J., & Hrncir, T. (2019) · Folia Microbiologica · doi:10.1007/s12223-018-00674-z · Cited by 74
Gut Microbiota in Neurological Disorders
Grochowska, M., Laskus, T., & Radkowski, M. (2019) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-019-00561-6 · Cited by 76
The Multibiome: The Intestinal Ecosystem's Influence on Immune Homeostasis, Health, and Disease
Filyk, H. A., & Osborne, L. C. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.10.007 · Cited by 71
Th17 cell pathogenicity in autoimmune disease
Park, E., & Ciofani, M. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01535-9 · Cited by 75
Intestinal Dysbiosis and Tryptophan Metabolism in Autoimmunity
Brown, J., Robusto, B. A., & Morel, L. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01741 · Cited by 68
The gut microbiota in pediatric multiple sclerosis and demyelinating syndromes
Tremlett, H. L., Zhu, F., Arnold, D. L., Bar‐Or, A., Bernstein, C. N., Bonner, C., Forbes, J. D., Graham, M., Hart, J., Knox, N., et al. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51476 · Cited by 70
Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?
Adamczyk-Sowa, M. H., Medrek, A., Madej, P., Michlicka, W., & Dobrakowski, P. P. (2017) · Journal of Immunology Research · doi:10.1155/2017/7904821 · Cited by 68
Cao, S., Budina, E., Raczy, M. M., Solanki, A., Nguyen, M., Beckman, T. N., Reda, J. W., Hultgren, K., Ang, P. S., Slezak, A. J., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01190-x · Cited by 77
Murakami, M., Iwamoto, J., Honda, A., Tsuji, T., Tamamushi, M., Ueda, H., Monma, T., Konishi, N., Yara, S., Hirayama, T. T., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy022 · Cited by 67
Role of environmental factors in multiple sclerosis
Zarghami, A., Li, Y., Claflin, S. B., van der Mei, I. A. F., & Taylor, B. V. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1978843 · Cited by 66
Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness
Yadav, M., Ali, S., Shrode, R. L., Shahi, S. K., Jensen, S. N., Hoang, J., Cassidy, S., Olalde, H. M., Guseva, N. V., Paullus, M., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264556 · Cited by 65
Klymiuk, I., Bambach, I., Patra, V., Trajanoski, S., & Wolf, P. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02012 · Cited by 65
Intestinal microbiome as a novel therapeutic target for local and systemic inflammation
Uchiyama, K., Naito, Y., & Takagi, T. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.03.006 · Cited by 65
CXCR3+ T cells in multiple sclerosis correlate with reduced diversity of the gut microbiome
Choileáin, S. N., Kleinewietfeld, M., Raddassi, K., Hafler, D. A., Ruff, W. E., & Longbrake, E. E. (2019) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2019.100032 · Cited by 63
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Shahi, S. K., Zarei, K., Guseva, N. V., & Mangalam, A. K. (2019) · Journal of Visualized Experiments · doi:10.3791/59980 · Cited by 89
The Ins and Outs of Central Nervous System Inflammation—Lessons Learned from Multiple Sclerosis
Ramaglia, V., Rojas, O. L., Naouar, I., & Gommerman, J. L. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-093019-124155 · Cited by 72
Singh, J., Vanlallawmzuali, Singh, A. K., Biswal, S., Zomuansangi, R., Lalbiaktluangi, C., Singh, B. P., Singh, P. K., Vellingiri, B., Iyer, M., et al. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104068 · Cited by 71
Clinical Evidence for the Microbiome in Inflammatory Diseases
Slingerland, A. E., Schwabkey, Z. I., Wiesnoski, D. H., & Jenq, R. R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00400 · Cited by 65
Gut dysbiosis and multiple sclerosis
Noto, D., & Miyake, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108380 · Cited by 65
The role of the gut microbiota and microbial metabolites in neuroinflammation
Haase, S., Wilck, N., Haghikia, A., Gold, R., Mueller, D. N., & Linker, R. A. (2020) · European Journal of Immunology · doi:10.1002/eji.201847807 · Cited by 65
Yadav, S., Dwivedi, A., Tripathi, A., & Tripathi, A. K. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.07.007 · Cited by 66
Giuffrè, M., Moretti, R., Campisciano, G., da Silveira, A. B. M., Monda, V., Comar, M., Bella, S. D., Antonello, R. M., Luzzati, R., & Crocè, L. S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113705 · Cited by 64
The influence of interferon β-1b on gut microbiota composition in patients with multiple sclerosis
Castillo-Álvarez, F., Pérez‐Matute, P., Oteo, J. A., & Marzo-Sola, M. E. (2020) · Neurología (English Edition) · doi:10.1016/j.nrleng.2020.05.006 · Cited by 62
What Are the Key Gut Microbiota Involved in Neurological Diseases? A Systematic Review
Bonnechère, B., Amin, N., & van Duijn, C. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213665 · Cited by 68
Metadata
- Authors
- Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., Chihara, N., Tomita, A., Sato, W., Kim, S.-W., Morita, H., Hattori, M., & Yamamura, T.
- Affiliations
- Juntendo University (JP)
- RIKEN Center for Integrative Medical Sciences (JP)
- The University of Tokyo (JP)
- National Institute of Neuroscience (JP)
- Azabu University (JP)
- Corresponding author
- Hattori, Masahira
- Yamamura, Takashi
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-09-14
- Volume
- 10
- Issue
- 9
- Pages
- e0137429
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4569432
- OpenAlex
- W2200372542
- Cited by
- 809
- References
- 41
- Citations by year
- 2026: 49 · 2025: 61 · 2024: 83 · 2023: 68 · 2022: 91 · 2021: 89 · 2020: 89 · 2019: 76 · 2018: 85 · 2017: 76 · 2016: 38 · 2015: 2
- FWCI
- 29.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministry of Health, Labour and Welfare
- University of Tokyo
- Japan Society for the Promotion of Science (24229006, 26293234)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- multiple sclerosis, gut microbiota, dysbiosis, Clostridium XIVa, Bacteroidetes, relapsing-remitting multiple sclerosis, experimental autoimmune encephalomyelitis, regulatory T cells, autoimmunity, 16S rRNA gene sequencing, fecal microbiota
- MeSH terms
- Gastrointestinal Microbiome, Adult, Clostridium, Female, Humans, Japan, Male, Multiple Sclerosis, RNA, Bacterial, RNA, Ribosomal, 16S, Sequence Analysis, RNA, Bacteroidetes, High-Throughput Nucleotide Sequencing, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
